CollPlant Biotechnologies (CLGN) Change in Inventory (2018 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Change in Inventory came in at -$32000.0 in Q4 2025, down 313.33% YoY from $15000.0 in Q4 2024, and down 328.57% on a QoQ basis from $14000.0 in Q3 2025.
CollPlant Biotechnologies (CLGN) Change in Inventory (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 8 years of Change in Inventory data on file, last reported at -$32000.0 in Q4 2025.
- Quarterly Change in Inventory fell 313.33% year-over-year to -$32000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $117000.0 (down 58.21% YoY) and the FY2025 annual result came in at -$129000.0, down 146.07% from the prior year.
- Change in Inventory retreated to -$32000.0 in Q4 2025, from $14000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $856000.0 in Q4 2023 to a low of -$345000.0 in Q1 2023.
- A 5-year average of $55894.7 and a median of $15000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory sank 1330.77% — and 2023, when it jumped 374.36%.
- Tracing CLGN's Change in Inventory over 5 years: stood at $181000.0 in 2021, then tumbled by 272.38% to -$312000.0 in 2022, then jumped by 374.36% to $856000.0 in 2023, then tumbled by 98.25% to $15000.0 in 2024, then slumped by 313.33% to -$32000.0 in 2025.
- The last three Change in Inventory figures came in at -$32000.0 (Q4 2025), $14000.0 (Q3 2025), and $120000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.23 Mn | 4.23 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Dec 31, 2023 | 856,000.00 |
| Dec 31, 2023 | 856,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Jun 30, 2023 | 190,000.00 |
| Jun 30, 2023 | 190,000.00 |